×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Heal... [14]
Institute of Ch... [13]
THE STATE KEY L... [13]
Authors
TAM KIN YIP [8]
LIN LIGEN [4]
WANG YITAO [3]
LEUNG CHUNG HANG [3]
CHEN XIUPING [3]
OUYANG DEFANG [3]
More...
Document Type
Journal article [15]
Review article [7]
Other [1]
Date Issued
2024 [4]
2022 [5]
2021 [6]
2020 [1]
2019 [2]
2018 [1]
More...
Language
英語English [21]
Source Publication
Drug Discovery ... [17]
DRUG DISCOVERY T... [5]
Drug discovery t... [1]
Indexed By
SCIE [21]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 23
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Dual-target inhibitors of cholinesterase and GSK-3beta to modulate Alzheimer's disease
Journal article
He Junqiu, TAM KIN YIP. Dual-target inhibitors of cholinesterase and GSK-3beta to modulate Alzheimer's disease[J]. Drug Discovery Today, 2024, 29(4), 1-8.
Authors:
He Junqiu
;
TAM KIN YIP
Adobe PDF
|
Favorite
|
TC[WOS]:
2
TC[Scopus]:
3
IF:
6.5
/
7.3
|
Submit date:2024/08/29
Gsk-3b
Cholinesterase
Dual-target Inhibitors
Alzheimer’s Disease
Drug Design Strategy
Dual-target inhibitors of cholinesterase and GSK-3β to modulate Alzheimer's disease
Other
2024-04-01
Authors:
He, Junqiu
;
Tam, Kin Yip
Favorite
|
TC[WOS]:
2
TC[Scopus]:
3
|
Submit date:2024/05/02
Alzheimer's Disease
Cholinesterase
Drug Design Strategy
Dual-target Inhibitors
Gsk-3β
Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: Screening natural products, small molecules and antibodies
Journal article
Jin, Haochun, Cui, Dianxin, Fan, Yu, Li, Guodong, Zhong, Zhangfeng, Wang, Yitao. Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: Screening natural products, small molecules and antibodies[J]. Drug Discovery Today, 2024, 29(3), 103885.
Authors:
Jin, Haochun
;
Cui, Dianxin
;
Fan, Yu
;
Li, Guodong
;
Zhong, Zhangfeng
; et al.
Favorite
|
TC[WOS]:
4
TC[Scopus]:
6
IF:
6.5
/
7.3
|
Submit date:2024/04/02
Antibodies
Bioaffinity Strategy
Drug Discovery
Natural Products
Small Molecule
Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy
Journal article
Wu, Ke Jia, Chen, Qi, Leung, Chung Hang, Sun, Ning, Gao, Fei, Chen, Zhaoyang. Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy[J]. Drug Discovery Today, 2024, 29(2), 103878.
Authors:
Wu, Ke Jia
;
Chen, Qi
;
Leung, Chung Hang
;
Sun, Ning
;
Gao, Fei
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
6.5
/
7.3
|
Submit date:2024/02/22
Chromatin Remodeling
Epigenetics
Heart Failure
Histone Modification
Pathological Cardiac Hypertrophy
Exosome-cargoed microRNAs: Potential therapeutic molecules for diabetic wound healing
Journal article
Ruohan Lou, Jiali Chen, Fei Zhou, Chunming Wang, Chung-Hang Leung, Ligen Lin. Exosome-cargoed microRNAs: Potential therapeutic molecules for diabetic wound healing[J]. Drug Discovery Today, 2022, 27(10).
Authors:
Ruohan Lou
;
Jiali Chen
;
Fei Zhou
;
Chunming Wang
;
Chung-Hang Leung
; et al.
Favorite
|
TC[WOS]:
28
TC[Scopus]:
27
IF:
6.5
/
7.3
|
Submit date:2022/10/07
Angiogenesis
Diabetic Foot Ulcers
Exosomes
Micrornas
Wound Healing
The development of small-molecule inhibitors targeting hexokinase 2
Journal article
Shen Wenying, Zhou Yan, TAM KIN YIP. The development of small-molecule inhibitors targeting hexokinase 2[J]. Drug Discovery Today, 2022, 27(9), 2574-2585.
Authors:
Shen Wenying
;
Zhou Yan
;
TAM KIN YIP
Adobe PDF
|
Favorite
|
TC[WOS]:
22
TC[Scopus]:
20
IF:
6.5
/
7.3
|
Submit date:2024/08/29
Cancer Metabolism
Hexokinase 2
Drug–target Binding
Selective Inhibition
Structure-based Molecular Design
Opportunities and challenges of physiologically based pharmacokinetic modeling in drug delivery
Review article
2022
Authors:
Wei Wang
;
Defang Ouyang
Favorite
|
TC[WOS]:
18
TC[Scopus]:
26
IF:
6.5
/
7.3
|
Submit date:2022/05/17
Inhalation
Injectable Formulation
Nanomedicine
Oral Formulation
Pbpk Modeling
Transdermal Formulations
The development of small-molecule inhibitors targeting hexokinase 2
Review article
2022
Authors:
Shan, Wenying
;
Zhou, Yan
;
Tam, Kin Yip
Favorite
|
TC[WOS]:
22
TC[Scopus]:
20
IF:
6.5
/
7.3
|
Submit date:2022/08/05
Cancer Metabolism
Hexokinase 2
Drug–target Binding
Selective Inhibition
Structure-based Molecular Design
The role of irisin in metabolic flexibility: Beyond adipose tissue browning
Journal article
Shengnan Shen, Qiwen Liao, Xiuping Chen, Cheng Peng, Ligen Lin. The role of irisin in metabolic flexibility: Beyond adipose tissue browning[J]. Drug Discovery Today, 2022, 27(8), 2261-2267.
Authors:
Shengnan Shen
;
Qiwen Liao
;
Xiuping Chen
;
Cheng Peng
;
Ligen Lin
Favorite
|
TC[WOS]:
9
TC[Scopus]:
13
IF:
6.5
/
7.3
|
Submit date:2022/05/17
Fndc5
Insulin Sensitivity
Irisin
Metabolic Flexibility
Obesity
Skeletal Muscle
Small molecules targeting ubiquitination to control inflammatory diseases
Journal article
Zheng-Qing Li, Xiuping Chen, Ying Wang. Small molecules targeting ubiquitination to control inflammatory diseases[J]. DRUG DISCOVERY TODAY, 2021, 26(10), 2414-2422.
Authors:
Zheng-Qing Li
;
Xiuping Chen
;
Ying Wang
Favorite
|
TC[WOS]:
5
TC[Scopus]:
4
IF:
6.5
/
7.3
|
Submit date:2021/12/08
Ubiquitin
Ubiquitination System
Inflammatory Diseases
Small Molecule Modulator